Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Colorectal Neoplasms 2Sarcoma, Kaposi 1Neoplasm Metastasis 1Myelodysplastic Syndromes 1Lymphoma 1Hematologic Neoplasms 1Graft vs Host Disease 1Colorectal Cancer Metastatic 1

Interventions

pembrolizumab 3Nivolumab 3Valganciclovir 2Filgrastim 2Etoposide 2Docetaxel 2valspodar 1talimogene laherparepvec 1liposomal doxorubicin 1lenvatinib 1fialuridine 1etoposide phosphate 1efineptakin alfa 1X-Rays 1Thalidomide 1Sunitinib 1Specimen Handling 1SUB1 protein, human 1Ritonavir 1Propranolol 1Peripheral Blood Stem Cell Transplantation 1Nevirapine 1Nelfinavir 1Maraviroc 1Magnetic Resonance Spectroscopy 1Lopinavir 1Indinavir 1Ifosfamide 1Gemcitabine 1Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Sarcoma, Kaposi × Maraviroc × Clear all
NCT01276236 2021-03-05

Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)

University of California, San Francisco

Phase 2 Completed
13 enrolled 16 charts
Sarcoma

Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡